Inhibition of platelet function during in vivo infusion of isosorbide mononitrates: Relationship between plasma drug concentration and hemodynamic effects

American Heart Journal

Volumn 119, Issue 4, 1990, Pages 855-862

  De Caterina, Raffaele ^a   Lombardi, Massimo ^a   Bernini, Walter ^a   Mazzone, Annamaria ^a   Giannessi, Daniela ^a   Moscarelli, Elena ^a   Weiss, Marija ^a   Lazzerini, Guido ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE 2 NITRATE; ISOSORBIDE 5 NITRATE; THROMBOXANE B2;

ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

COMPARATIVE STUDY; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMODYNAMICS; HUMAN; INFUSIONS, INTRAVENOUS; ISOSORBIDE DINITRATE; MALE; MIDDLE AGE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SUPPORT, NON-U.S. GOV'T; THROMBOXANE B2;

EID: 0025338045     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/S0002-8703(05)80323-0     Document Type: Article

References (23)

1. Pharmacokinetics of ISDN, sustained-release ISDN, and IS-5-MN
2. Pharmacokinetics of isosorbide mononitrates in human subjects
3. Beneficial effects of isosorbide-5-mononitrate on exercise performance in patients with chronic stable angina pectoris
4. The efficacy of IS-5-MN in patients with ischemic heart disease: a pilot study
5. Efficacy of IS-5-MN (ISMO 20) in patients with coronary artery disease and impaired left ventricular function
6. Organic nitrates: direct antiplatelet effects and synergism with prostacyclin
7. 2 generation during ex-vivo platelet aggregation
8. Low-dose aspirin in patients recovering from myocardial infarction. Evidence for a selective inhibition of thromboxanerelated platelet function
9. Inhibition of platelet function by injectable isosorbide dinitrate
10. Quantitative determination of isosorbide dinitrate and two metabolites in plasma
11. Inhibition of platelet function by organic nitrate vasodilators
12. Nitroglycerin, prostacyclin and platelet function
13. N-acetyl-cysteine potentiates inhibition of platelet aggregation by nitroglycerin
14. Reduced thiols and the effect of intravenous nitroglycerin on platelet aggregation
15. The use of nitrates in the treatment of ischemic heart disease
16. Nitrate therapy in stable angina pectoris
17. The relation of coronary thrombosis to ischaemic myocardial necrosis
18. Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death
19. Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects
20. Systemic and coronary vascular effects of the 2-and the 5-mononitrate esters of isosorbide dinitrate
21. Evidence for the inhibitory role of the guanosine 3′-5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators
22. Sulphydryl requirement for relaxation of vascular smooth muscle
23. Roles of cAMP and cGMP in the synergistic inhibitory effects of nitrovasodilators and PGE1 on platelet aggregation and degranulation